About
Madrigal Pharma
MDGL.US
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Profile
- Company Name
- Madrigal Pharmaceuticals, Inc.
- Market
- NasdaqGS
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- www.madrigalpharma.com